Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Shares Up 1.3% - Time to Buy?

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report)'s share price shot up 1.3% on Tuesday . The company traded as high as $7.12 and last traded at $7.09. 465,642 shares changed hands during mid-day trading, a decline of 45% from the average session volume of 846,056 shares. The stock had previously closed at $7.00.

Wall Street Analysts Forecast Growth

Separately, Hsbc Global Res raised Bayer Aktiengesellschaft to a "hold" rating in a report on Monday, April 28th.

Bayer Aktiengesellschaft Stock Performance

The stock has a market capitalization of $27.74 billion, a P/E ratio of -27.15 and a beta of 0.84. The firm's 50 day simple moving average is $6.32 and its two-hundred day simple moving average is $5.78. The company has a quick ratio of 0.81, a current ratio of 1.32 and a debt-to-equity ratio of 1.19.

Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) last released its quarterly earnings results on Tuesday, May 13th. The company reported $0.65 earnings per share for the quarter, topping the consensus estimate of $0.63 by $0.02. The business had revenue of $15.27 billion for the quarter, compared to analysts' expectations of $13.39 billion. Bayer Aktiengesellschaft had a negative net margin of 2.02% and a positive return on equity of 16.90%. As a group, analysts forecast that Bayer Aktiengesellschaft will post 1.31 earnings per share for the current fiscal year.

Bayer Aktiengesellschaft Increases Dividend

The company also recently disclosed a dividend, which was paid on Monday, May 12th. Investors of record on Wednesday, April 30th were paid a dividend of $0.0224 per share. The ex-dividend date was Tuesday, April 29th. This represents a yield of 0.38%. This is a boost from Bayer Aktiengesellschaft's previous dividend of $0.02. Bayer Aktiengesellschaft's payout ratio is currently -2.17%.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.